Loading...
Precigen Inc (PGEN) is not a strong buy at this moment for a beginner investor with a long-term strategy. While there are some positive technical indicators, the lack of significant positive catalysts, weak financial performance, and hedge fund selling trends suggest a cautious approach. Holding the stock or waiting for better entry points is recommended.
The technical indicators show mixed signals. The MACD is positive and expanding, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the RSI is neutral at 56.498, and the pre-market price is down 0.63%. Key support and resistance levels are Pivot: 4.583, R1: 4.926, S1: 4.239, R2: 5.139, S2: 4.026.

The MACD and moving averages are bullish, indicating potential upward momentum.
Hedge funds are selling heavily, with an 801.59% increase in selling activity over the last quarter. The company's net income remains significantly negative (-$325.34M) despite improvement, and gross margin dropped drastically (-1198.30% YoY). There is no recent news or congress trading data to support a positive sentiment.
In Q3 2025, revenue increased by 206.61% YoY to $2.92M. However, net income remains negative at -$325.34M, despite improving by 1256.84% YoY. EPS improved to -1.06, up 1077.78% YoY, but the gross margin dropped significantly to 64.58, down -1198.30% YoY.
No recent analyst rating or price target changes are available for PGEN. Wall Street sentiment is unclear due to the lack of data.